IMA · ImageneBio, Inc.
$5.51
-0.10 (-1.78%)
At close · Aug 21
Market Cap
$64.36M
Shares
11.35M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$800K
-77.1%
FY2025
Net Income
-$45.35M
-24%
FY2025
Operating Margin
-6056.38%
-4999.2pp
FY2025
Diluted EPS
-$9.64
+56.4%
FY2025
Operating Cash Flow
-$47.84M
-124.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| — | $800K | $3.5M | $9.16M | $15.62M | $30.99M | $9.19M | |
| $31.46M | $28.53M | $32.11M | $59.65M | $64.32M | $47.11M | $44.85M | |
| $27.5M | $20.73M | $8.39M | $24.93M | $22.2M | $18.02M | $8.87M | |
| — | $400K | $1.1M | — | — | — | — | |
| $2.9M | — | $4.42M | — | — | — | — | |
| $58.96M | $49.25M | $40.5M | $84.58M | $86.52M | $65.12M | $53.71M | |
| -$58.96M | -$48.45M | -$37M | -$75.42M | -$70.9M | -$34.14M | -$44.52M | |
| — | -6056.38% | -1057.14% | -823.33% | -453.99% | -110.18% | -484.22% | |
| — | -$48.05M | -$35.9M | — | — | — | — | |
| — | — | — | $7.11M | $2.15M | $23K | — | |
| $6.15M | $2.75M | $445K | $7.09M | $2.14M | $23K | $263K | |
| — | — | — | -$5000 | -$173K | — | — | |
| -$52.81M | -$45.7M | -$36.56M | -$68.33M | -$68.77M | — | — | |
| -$367K | -$350K | $13K | -$162K | $0 | $0 | — | |
| -$52.48M | -$45.35M | -$36.57M | -$68.17M | -$68.77M | -$34.12M | -$44.26M | |
| — | -5668.62% | -1044.8% | -744.17% | -440.29% | -110.1% | -481.36% | |
| -$53.33M | -$52.4M | -$48.38M | — | — | — | — | |
| -$52.54M | -$45.29M | -$36.61M | -$67.45M | -$69.53M | -$34.12M | — | |
| USD/shares | — | -$9.64 | -$22.10 | -$19.56 | -$22.80 | -$14.64 | — |
| USD/shares | — | -$9.64 | -$22.10 | -$19.56 | -$22.80 | -$14.64 | — |
| shares | — | 4.87M | 1.19M | 3.48M | 3.02M | 2.33M | 230.46K |
| shares | — | — | 4.02M | 3.48M | 3.02M | 2.33M | 230.46K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.27×
EV/EBIT
—
Peer median 18.32×
P/E (TTM)
—
Peer median 9.32×
Peer medians compare against the 299 similar-size Biotechnology companies (of 545 listed).
Key facts
CIK
1835579
CUSIP
45175G207
13F (30d)
36 filings
36 filers
Visit website
Investor relations